Generic placeholder image

Current Bioactive Compounds

Author(s): Ana Martinho, Sara M. Silva, Tiago Rosado, Fernanda C. Domingues, Samuel Silvestre, Luiza Breitenfeld, Gilberto Alves, Ana P. Duarte and Eugenia Gallardo*

DOI: 10.2174/1573407214666181026111431

DownloadDownload PDF Flyer Cite As
Valeriana spp.: Biological Activities and New In vitro and In vivo Perspectives

Page: [210 - 242] Pages: 33

  • * (Excluding Mailing and Handling)

Explore Articles
About Journal
For Authors
For Editors
For Reviewers

Abstract

Background: Valerian extract is widely used in dietary supplements as well as in conventional, traditional and alternative medicines. It is one of the most used herbal plants for the treatment of several disorders, mainly related to the digestive and the nervous systems. Dozens of chemical constituents with pharmacological and therapeutic properties were identified in essential oils and/or other extracts of valerian’s roots, rhizomes and aerial parts. This review summarizes and updates the current knowledge about the pharmacological properties of valerian, highlighting the most recent clinical, in vitro and in vivo findings, and intends to identify and propose future directions for further research regarding the effective biological effects of Valeriana spp.

Methods: This review analyzed the scientific literature published in PubMed, Science Direct and Web of Science.

Results: Some reports are contradictory or inconclusive, probably due to the presence of chemically distinct chemotypes within a species of Valeriana or to different approaches adopted in different studies. Also, there are a number of studies showing that co-administration of herbal supplements and drugs may promote pharmacokinetic and pharmacodynamic herb-drug interactions.

Conclusion: It is of utmost importance to clarify the state of the art related to Valeriana spp. therapeutic properties and their effects on metabolism.

Keywords: Valeriana spp., biological activities, pharmacological properties, in vitro, in vivo, clinical studies.

Graphical Abstract

[1]
Patocka, J.; Jaki, J. Biomedically relevant chemical constituents of Valeriana officinalis. J. Appl. Biomed., 2010, 8(1), 11-18.
[http://dx.doi.org/10.2478/v10136-009-0002-z]
[2]
Oliva, I.; González-Trujano, M.E.; Arrieta, J.; Enciso-Rodríguez, R.; Navarrete, A. Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice. Phytother. Res., 2004, 18(4), 290-296.
[http://dx.doi.org/10.1002/ptr.1389] [PMID: 15162363]
[3]
Hikino, H.; Ono, M.; Takemoto, T. [Constituents of wild Japanese valerian root. 2]. Yakugaku Zasshi, 1972, 92(4), 479-481.
[http://dx.doi.org/10.1248/yakushi1947.92.4_479] [PMID: 5065447]
[4]
Nishiya, K.; Kimura, T.; Takeya, K.; Itokawa, H. Sesquiterpenoids and iridoid glycosides from Valeriana fauriei. Phytochemistry, 1992, 31(10), 3511-3514.
[http://dx.doi.org/10.1016/0031-9422(92)83718-E] [PMID: 1368860]
[5]
Sakamoto, T.; Mitani, Y.; Nakajima, K. Psychotropic effects of Japanese valerian root extract. Chem. Pharm. Bull. (Tokyo), 1992, 40(3), 758-761.
[http://dx.doi.org/10.1248/cpb.40.758] [PMID: 1611689]
[6]
Eadie, M.J. Could valerian have been the first anticonvulsant? Epilepsia, 2004, 45(11), 1338-1343.
[http://dx.doi.org/10.1111/j.0013-9580.2004.27904.x] [PMID: 15509234]
[7]
De Feo, V.; Faro, C. Pharmacological effects of extracts from Valeriana adscendens Trel. II. Effects on GABA uptake and amino acids. Phytother. Res., 2003, 17(6), 661-664.
[http://dx.doi.org/10.1002/ptr.1225] [PMID: 12820236]
[8]
Houghton, P.J. The scientific basis for the reputed activity of Valerian. J. Pharm. Pharmacol., 1999, 51(5), 505-512.
[http://dx.doi.org/10.1211/0022357991772772] [PMID: 10411208]
[9]
Taibi, D.M.; Bourguignon, C.; Taylor, A.G. Valerian use for sleep disturbances related to rheumatoid arthritis. Holist. Nurs. Pract., 2004, 18(3), 120-126.
[http://dx.doi.org/10.1097/00004650-200405000-00004] [PMID: 15222600]
[10]
Isetts, B. Herbal Products, Tracy, T.; Kingston, R. Humana Press,. 2007, 55-70.
[11]
Hamedi, A.; Pasdaran, A.; Zebarjad, Z.; Moein, M. a survey on chemical constituents and indications of aromatic waters soft drinks (Hydrosols) used in persian nutrition culture and folk medicine for neurological disorders and mental health. J. Evid. Based Complementary Altern. Med., 2017, 22(4), 744-752.
[http://dx.doi.org/10.1177/2156587217714145] [PMID: 28633539]
[12]
Kumar, V. Potential medicinal plants for CNS disorders: an overview. Phytother. Res., 2006, 20(12), 1023-1035.
[http://dx.doi.org/10.1002/ptr.1970] [PMID: 16909441]
[13]
Müller, S.F.; Klement, S. A combination of valerian and lemon balm is effective in the treatment of restlessness and dyssomnia in children. Phytomedicine, 2006, 13(6), 383-387.
[http://dx.doi.org/10.1016/j.phymed.2006.01.013] [PMID: 16487692]
[14]
https://ods.od.nih.gov/factsheets/Valerian-HealthProfessional/
[15]
Kim, J.; Lee, S.L.; Kang, I.; Song, Y.A.; Ma, J.; Hong, Y.S.; Park, S.; Moon, S.I.; Kim, S.; Jeong, S.; Kim, J.E. Natural products from single plants as sleep aids: A systematic review. J. Med. Food, 2018, 21(5), 433-444.
[http://dx.doi.org/10.1089/jmf.2017.4064] [PMID: 29356580]
[16]
Wagner, H.; Schaette, R.; Horhamme, L.; Holzl, J. Dependence of valepotriate and ethereal oil content in Valeriana officinalis LSL upon different exogenous and endogenous factors. Arzneimittelforschung, 1972, 22(7), 1204-1209.
[PMID: 4678131]
[17]
Becker, H.; Schrall, R. Valepotriates in tissue cultures of nine different Valerianaceae species in comparison to literature data of the intact plants. J. Nat. Prod., 1980, 43(6), 721-723.
[http://dx.doi.org/10.1021/np50012a004] [PMID: 20707394]
[18]
Jugran, A.K.; Bahukhandi, A.; Dhyani, P.; Bhatt, I.D.; Rawal, R.S.; Nandi, S.K. Impact of altitudes and habitats on valerenic acid, total phenolics, flavonoids, tannins, and antioxidant activity of Valeriana jatamansi. Appl. Biochem. Biotechnol., 2016, 179(6), 911-926.
[http://dx.doi.org/10.1007/s12010-016-2039-2] [PMID: 26971960]
[19]
Ricigliano, V.; Kumar, S.; Kinison, S.; Brooks, C.; Nybo, S.E.; Chappell, J.; Howarth, D.G. Regulation of sesquiterpenoid metabolism in recombinant and elicited Valeriana officinalis hairy roots. Phytochemistry, 2016, 125, 43-53.
[http://dx.doi.org/10.1016/j.phytochem.2016.02.011] [PMID: 26920719]
[20]
Fernández, S.; Wasowski, C.; Paladini, A.C.; Marder, M. Sedative and sleep-enhancing properties of linarin, a flavonoid-isolated from Valeriana officinalis. Pharmacol. Biochem. Behav., 2004, 77(2), 399-404.
[http://dx.doi.org/10.1016/j.pbb.2003.12.003] [PMID: 14751470]
[21]
Marder, M.; Viola, H.; Wasowski, C.; Fernández, S.; Medina, J.H.; Paladini, A.C. 6-methylapigenin and hesperidin: new valeriana flavonoids with activity on the CNS. Pharmacol. Biochem. Behav., 2003, 75(3), 537-545.
[http://dx.doi.org/10.1016/S0091-3057(03)00121-7] [PMID: 12895671]
[22]
Wang, R.J.; Chen, H.M.; Yang, F.; Deng, Y.; Ao, H.; Xie, X.F.; Li, H.X.; Zhang, H.; Cao, Z.X.; Zhu, L.X.; Chen, Y.; Peng, C.; Tan, Y.Z. Iridoids from the roots of Valeriana jatamansi Jones. Phytochemistry, 2017, 141, 156-161.
[http://dx.doi.org/10.1016/j.phytochem.2017.05.010] [PMID: 28623738]
[23]
Hendriks, H.; Bos, R.; Woerdenbag, H.J.; Koster, A.S. Central nervous depressant activity of valerenic Acid in the mouse. Planta Med., 1985, 51(1), 28-31.
[http://dx.doi.org/10.1055/s-2007-969384] [PMID: 17340394]
[24]
Veith, J.; Schneider, G.; Lemmer, B.; Willems, M. [The effect of degradation products of valepotriates on the motor activity of light-dark synchronized mice]. Planta Med., 1986, (3), 179-183.
[http://dx.doi.org/10.1055/s-2007-969116] [PMID: 3749340]
[25]
Franck, B.; Petersen, U.; Hüper, F. Valerianie, a tertiary monoterpene alkaloid from valerian (1). Angew. Chem. Int. Ed. Engl., 1970, 9(11), 891-891.
[http://dx.doi.org/10.1002/anie.197008911] [PMID: 4993355]
[26]
Barnes, J.; Anderson, L.A.; Phillipson, J.D. Herbal Medicines; Pharmaceutical Press: London, 2007.
[27]
Upton, R.; Pharmacopoeia, A.H. Valerian Root: Valeriana Officinalis: Analytical, Quality Control, and Therapeutic Monograph; American Herbal Pharmacopoeia, 1999.
[28]
Evans, W.C. Trease and Evans’ Pharmacognosy; Elsevier Health Sciences: UK, 2009.
[29]
Heinrich, M.; Barnes, J.; Prieto-Garcia, J.; Gibbons, S.; Williamson, E. Fundamentals of Pharmacognosy and Phytotherapy, 3rd ed; Churchill Livingstone, Elsevier, 2018.
[30]
Liu, Y.H.; Wu, P.Q.; Hu, Q.L.; Pei, Y.J.; Qi, F.M.; Zhang, Z.X.; Fei, D.Q. Cytotoxic and antibacterial activities of iridoids and sesquiterpenoids from Valeriana jatamansi. Fitoterapia, 2017, 123, 73-78.
[http://dx.doi.org/10.1016/j.fitote.2017.09.011] [PMID: 28941743]
[31]
Wang, M.Y.; Zhai, Y.S.; Liang, C.H. Two new guaiane-type sesquiterpenoids from Valeriana hardwickii and their cytotoxicity. J. Asian Nat. Prod. Res., 2017, 19(10), 987-992.
[http://dx.doi.org/10.1080/10286020.2017.1339350] [PMID: 28649852]
[32]
Chen, H.W.; He, X.H.; Yuan, R.; Wei, B.J.; Chen, Z.; Dong, J.X.; Wang, J. Sesquiterpenes and a monoterpenoid with acetylcholinesterase (AchE) inhibitory activity from Valeriana officinalis var. latiofolia in vitro and in vivo. Fitoterapia, 2016, 110, 142-149.
[http://dx.doi.org/10.1016/j.fitote.2016.03.011] [PMID: 26976216]
[33]
Hendriks, H.; Bos, R.; Allersma, D.P.; Malingré, T.M.; Koster, A.S. Pharmacological screening of valerenal and some other components of essential oil of Valeriana officinalis. Planta Med., 1981, 42(1), 62-68.
[http://dx.doi.org/10.1055/s-2007-971547] [PMID: 7255569]
[34]
Dewick, P.M. Medicinal Natural Products: A Biosynthetic Approach; Wiley, 2009.
[http://dx.doi.org/10.1002/9780470742761]
[35]
Funke, E.D.; Friedrich, H. [Valepotriates in the aerial parts of some more valerianaceae species (author’s transl)]. Planta Med., 1975, 28(3), 215-224.
[http://dx.doi.org/10.1055/s-0028-1097856] [PMID: 1197430]
[36]
Houghton, P.J. The biological activity of Valerian and related plants. J. Ethnopharmacol., 1988, 22(2), 121-142.
[http://dx.doi.org/10.1016/0378-8741(88)90123-7] [PMID: 3287008]
[37]
Fernández, S.P.; Wasowski, C.; Paladini, A.C.; Marder, M. Synergistic interaction between hesperidin, a natural flavonoid, and diazepam. Eur. J. Pharmacol., 2005, 512(2-3), 189-198.
[http://dx.doi.org/10.1016/j.ejphar.2005.02.039] [PMID: 15840404]
[38]
Rahman, A-u. Studies in natural products chemistry; Elsevier: Amsterdam, New York, 1988.
[39]
Becker, H.; Chavadej, S. Valepotriate production of normal and colchicine-treated cell suspension cultures of Valeriana wallichii. J. Nat. Prod., 1985, 48(1), 17-21.
[http://dx.doi.org/10.1021/np50037a003] [PMID: 4009183]
[40]
Johnson, R.; Waller, G. Isolation of actinidine from Valeriana officinalis. Phytochemistry, 1971, 10(12), 3334-3335.
[http://dx.doi.org/10.1016/S0031-9422(00)97426-0]
[41]
Sharma, M.; Jain, U.K.; Patel, A.; Gupta, N. A comprehensive pharmacognostic report on valerian. Int. J. Pharm. Sci. Res., 2010, 1(7), 6-40.
[42]
Evans, W.C.; Evans, D. Trease and Evans Pharmacognosy; W.B. Saunders, 2002.
[43]
Janot, M.M.; Guilhem, J.; Contz, O.; Venera, G.; Cionga, E. Contribution to the study of valerian alkaloid (Valeriana-officinalis, l) - actinidine and naphtyridylmethylketone, a new alcaloid. Ann. Pharm. Fr., 1979, 37(9-10), 413-420.
[PMID: 547813]
[44]
Bos, R.; Woerdenbag, H.J.; De Smet, P.A.G.M.; Scheffer, J.J.C. Valeriana Species. Adverse Effects of Herbal Drugs;; De Smet, P.A.G.M.; Keller, K.; Hänsel, R.; Chandler, R.F., Eds.; Springer: Berlin, Heidelberg, Vol. 3. , 1997.
[http://dx.doi.org/10.1007/978-3-642-60367-9_15]
[45]
Caron, M.F.; Riedlinger, J.E. Valerian: A Practical review for clinicians. Nutr. Clin. Care, 1999, 2(4), 250-257.
[http://dx.doi.org/10.1046/j.1523-5408.1999.00114.x]
[46]
Organization, W.H. WHO Monographs on Selected Medicinal Plants; World Health Organization, 1999.
[47]
Carretero, E.; Terpenos, I.I. Iridóides y sesquiterpenos. Panorama Actual Medicamento, 2000, 24(239), 1115-1119.
[48]
Ribeiro, C.A.; Balestro, F.; Grando, V.; Wajner, M. Isovaleric acid reduces Na+, K+-ATPase activity in synaptic membranes from cerebral cortex of young rats. Cell. Mol. Neurobiol., 2007, 27(4), 529-540.
[http://dx.doi.org/10.1007/s10571-007-9143-3] [PMID: 17394058]
[49]
Yuan, C.S.; Mehendale, S.; Xiao, Y.; Aung, H.H.; Xie, J.T.; Ang-Lee, M.K. The gamma-aminobutyric acidergic effects of valerian and valerenic acid on rat brainstem neuronal activity. Anesth. Analg., 2004, 98(2), 353-358.
[http://dx.doi.org/10.1213/01.ANE.0000096189.70405.A5] [PMID: 14742369]
[50]
Trauner, G.; Khom, S.; Baburin, I.; Benedek, B.; Hering, S.; Kopp, B. Modulation of GABAA receptors by valerian extracts is related to the content of valerenic acid. Planta Med., 2008, 74(1), 19-24.
[http://dx.doi.org/10.1055/s-2007-993761] [PMID: 18095218]
[51]
Jacobo-Herrera, N.J.; Vartiainen, N.; Bremner, P.; Gibbons, S.; Koistinaho, J.; Heinrich, M. NF-kappaB modulators from Valeriana officinalis. Phytother. Res., 2006, 20(10), 917-919.
[http://dx.doi.org/10.1002/ptr.1972] [PMID: 16909443]
[52]
Dewick, P.M. The Mevalonate and Methylerythritol Phosphate Pathways: Terpenoids and Steroids. Medicinal Natural Products; John Wiley & Sons, Ltd, 2009, pp. 187-310.
[53]
Rücker, G.; Tautges, J. [The structure of jatamansic acid (author’s transl)]. Arch. Pharm. (Weinheim), 1974, 307(10), 791-795.
[PMID: 4417340]
[54]
Hazelhoff, B.; Malingré, T.M.; Meijer, D.K.F. Antispasmodic effects of valeriana compounds: an in-vivo and in-vitro study on the guinea-pig ileum. Arch. Int. Pharmacodyn. Ther., 1982, 257(2), 274-287.
[PMID: 7114974]
[55]
Hazelhoff, B.; Jellema, R.; Grobben, H.; Malingré, T.M. Separation of valtrate and isovaltrate by means of preparative liquid chromatography. Pharm. Weekbl. Sci., 1982, 4(1), 21-24.
[http://dx.doi.org/10.1007/BF02112353] [PMID: 7070947]
[56]
Santos, M.S.; Ferreira, F.; Cunha, A.P.; Carvalho, A.P.; Macedo, T. An aqueous extract of valerian influences the transport of GABA in synaptosomes. Planta Med., 1994, 60(3), 278-279.
[http://dx.doi.org/10.1055/s-2006-959476] [PMID: 8073095]
[57]
Santos, M.S.; Ferreira, F.; Faro, C.; Pires, E.; Carvalho, A.P.; Cunha, A.P.; Macedo, T. The amount of GABA present in aqueous extracts of valerian is sufficient to account for [3H]GABA release in synaptosomes. Planta Med., 1994, 60(5), 475-476.
[http://dx.doi.org/10.1055/s-2006-959538] [PMID: 7997482]
[58]
Lovkova, M.; Buzuk, G. N.; Sokolova, S. M.; Kliment'eva, N. I.; Ponomareva, S. M.; Shelepova, O. V.; Vorotnitskaia, I. E. [Medicinal plants-concentrators of chromium. The role of chromium in alkaloid metabolism] Izvestiia Akademii nauk. Seriia biologicheskaia/ Rossiiskaia akademiia nauk, 1996, 5, 552-564.
[59]
Jarema, M. Herbal drug treatment. Neuroendocrinol. Lett., 2008, 29(Suppl. 1), 93-104.
[PMID: 19029875]
[60]
Dietz, B.M.; Mahady, G.B.; Pauli, G.F.; Farnsworth, N.R. Valerian extract and valerenic acid are partial agonists of the 5-HT5a receptor in vitro. Brain Res. Mol. Brain Res., 2005, 138(2), 191-197.
[http://dx.doi.org/10.1016/j.molbrainres.2005.04.009] [PMID: 15921820]
[61]
Khom, S.; Baburin, I.; Timin, E.; Hohaus, A.; Trauner, G.; Kopp, B.; Hering, S. Valerenic acid potentiates and inhibits GABA(A) receptors: molecular mechanism and subunit specificity. Neuropharmacology, 2007, 53(1), 178-187.
[http://dx.doi.org/10.1016/j.neuropharm.2007.04.018] [PMID: 17585957]
[62]
Lacher, S.K.; Mayer, R.; Sichardt, K.; Nieber, K.; Müller, C.E. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors. Biochem. Pharmacol., 2007, 73(2), 248-258.
[http://dx.doi.org/10.1016/j.bcp.2006.09.029] [PMID: 17097622]
[63]
Francis, A.J.P.; Dempster, R.J.W. Effect of valerian, Valeriana edulis, on sleep difficulties in children with intellectual deficits: randomised trial. Phytomedicine, 2002, 9(4), 273-279.
[http://dx.doi.org/10.1078/0944-7113-00110] [PMID: 12120807]
[64]
Willey, L.B.; Mady, S.P.; Cobaugh, D.J.; Wax, P.M. Valerian overdose: a case report. Vet. Hum. Toxicol., 1995, 37(4), 364-365.
[PMID: 8540231]
[65]
Restani, P.; Di Lorenzo, C.; Garcia-Alvarez, A.; Badea, M.; Ceschi, A.; Egan, B.; Dima, L.; Lüde, S.; Maggi, F.M.; Marculescu, A.; Milà-Villarroel, R.; Raats, M.M.; Ribas-Barba, L.; Uusitalo, L.; Serra-Majem, L. Adverse effects of plant food supplements self-reported by consumers in the PlantLIBRA survey involving six European countries. PLoS One, 2016, 11(2)e0150089
[http://dx.doi.org/10.1371/journal.pone.0150089] [PMID: 26928206]
[66]
Schulz, V. Rational Phytotherapy: A Reference Guide for Physicians and Pharmacists; Springer, 2004.
[http://dx.doi.org/10.1007/978-3-662-09666-6]
[67]
Petkov, V. Plants and hypotensive, antiatheromatous and coronarodilatating action. Am. J. Chin. Med., 1979, 7(3), 197-236.
[http://dx.doi.org/10.1142/S0192415X79000180] [PMID: 574353]
[68]
Wagner, H.; Jurcic, K. [On the spasmolytic activity of valeriana extracts (author’s transl)]. Planta Med., 1979, 37(1), 84-86.
[http://dx.doi.org/10.1055/s-0028-1097303] [PMID: 504481]
[69]
Buchbauer, G.; Jäger, W.; Jirovetz, L.; Meyer, F.; Dietrich, H. [Effects of valerian root oil, borneol, isoborneol, bornyl acetate and isobornyl acetate on the motility of laboratory animals (mice) after inhalation]. Pharmazie, 1992, 47(8), 620-622.
[PMID: 1438515]
[70]
Usami, N.; Okuda, T.; Yoshida, H.; Kimura, T.; Watanabe, K.; Yoshimura, H.; Yamamoto, I. Synthesis and pharmacological evaluation in mice of halogenated cannabidiol derivatives. Chem. Pharm. Bull. (Tokyo), 1999, 47(11), 1641-1645.
[http://dx.doi.org/10.1248/cpb.47.1641] [PMID: 10605059]
[71]
Neuhaus, W.; Trauner, G.; Gruber, D.; Oelzant, S.; Klepal, W.; Kopp, B.; Noe, C.R. Transport of a GABAA receptor modulator and its derivatives from Valeriana officinalis L. s. l. across an in vitro cell culture model of the blood-brain barrier. Planta Med., 2008, 74(11), 1338-1344.
[http://dx.doi.org/10.1055/s-2008-1081343] [PMID: 18704879]
[72]
Schumacher, B.; Scholle, S.; Hölzl, J.; Khudeir, N.; Hess, S.; Müller, C.E. Lignans isolated from valerian: identification and characterization of a new olivil derivative with partial agonistic activity at A(1) adenosine receptors. J. Nat. Prod., 2002, 65(10), 1479-1485.
[http://dx.doi.org/10.1021/np010464q] [PMID: 12398547]
[73]
Bodesheim, U.; Hölzl, J. [Isolation and receptor binding properties of alkaloids and lignans from Valeriana officialis L]. Pharmazie, 1997, 52(5), 386-391.
[PMID: 9229719]
[74]
Dalla Corte, C.L.; Fachinetto, R.; Colle, D.; Pereira, R.P.; Avila, D.S.; Villarinho, J.G.; Wagner, C.; Pereira, M.E.; Nogueira, C.W.; Soares, F.A.; Rocha, J.B.T. Potentially adverse interactions between haloperidol and valerian. Food Chem. Toxicol., 2008, 46(7), 2369-2375.
[http://dx.doi.org/10.1016/j.fct.2008.03.019] [PMID: 18474410]
[75]
Budzinski, J.W.; Foster, B.C.; Vandenhoek, S.; Arnason, J.T. An in vitro evaluation of human cytochrome P450 3A4 inhibition by selected commercial herbal extracts and tinctures. Phytomedicine, 2000, 7(4), 273-282.
[http://dx.doi.org/10.1016/S0944-7113(00)80044-6] [PMID: 10969720]
[76]
Lefebvre, T.; Foster, B.C.; Drouin, C.E.; Krantis, A.; Livesey, J.F.; Jordan, S.A.; Jordan, S.A. In vitro activity of commercial valerian root extracts against human cytochrome P450 3A4. J. Pharm. Pharm. Sci., 2004, 7(2), 265-273.
[PMID: 15367385]
[77]
Strandell, J.; Neil, A.; Carlin, G. An approach to the in vitro evaluation of potential for cytochrome P450 enzyme inhibition from herbals and other natural remedies. Phytomedicine, 2004, 11(2-3), 98-104.
[http://dx.doi.org/10.1078/0944-7113-00379] [PMID: 15070158]
[78]
Hellum, B.H.; Hu, Z.; Nilsen, O.G. The induction of CYP1A2, CYP2D6 and CYP3A4 by six trade herbal products in cultured primary human hepatocytes. Basic Clin. Pharmacol. Toxicol., 2007, 100(1), 23-30.
[http://dx.doi.org/10.1111/j.1742-7843.2007.00011.x] [PMID: 17214607]
[79]
Bogacz, A.; Mrozikiewicz, P.M.; Karasiewicz, M.; Bartkowiak-Wieczorek, J.; Majchrzycki, M.; Mikolajczak, P.L.; Ozarowski, M.; Grzeskowiak, E. The influence of standardized Valeriana officinalis extract on the CYP3A1 gene expression by nuclear receptors in in vivo model. BioMed Res. Int., 2014, 2014819093
[http://dx.doi.org/10.1155/2014/819093] [PMID: 25302309]
[80]
Donovan, J.L.; DeVane, C.L.; Chavin, K.D.; Wang, J.S.; Gibson, B.B.; Gefroh, H.A.; Markowitz, J.S. Multiple night-time doses of valerian (Valeriana officinalis) had minimal effects on CYP3A4 activity and no effect on CYP2D6 activity in healthy volunteers. Drug Metab. Dispos., 2004, 32(12), 1333-1336.
[http://dx.doi.org/10.1124/dmd.104.001164] [PMID: 15328251]
[81]
Izzo, A.A. Interactions between herbs and conventional drugs: overview of the clinical data. Med. Princ. Pract., 2012, 21(5), 404-428.
[http://dx.doi.org/10.1159/000334488] [PMID: 22236736]
[82]
Gurley, B.J.; Gardner, S.F.; Hubbard, M.A.; Williams, D.K.; Gentry, W.B.; Khan, I.A.; Shah, A. In vivo effects of goldenseal, kava kava, black cohosh, and valerian on human cytochrome P450 1A2, 2D6, 2E1, and 3A4/5 phenotypes. Clin. Pharmacol. Ther., 2005, 77(5), 415-426.
[http://dx.doi.org/10.1016/j.clpt.2005.01.009] [PMID: 15900287]
[83]
Mooiman, K.D.; Maas-Bakker, R.F.; Hendrikx, J.J.; Bank, P.C.; Rosing, H.; Beijnen, J.H.; Schellens, J.H.; Meijerman, I. The effect of complementary and alternative medicines on CYP3A4-mediated metabolism of three different substrates: 7-benzyloxy-4-trifluoromethyl-coumarin, midazolam and docetaxel. J. Pharm. Pharmacol., 2014, 66(6), 865-874.
[http://dx.doi.org/10.1111/jphp.12208] [PMID: 24392691]
[84]
Hellum, B.H.; Nilsen, O.G. In vitro inhibition of CYP3A4 metabolism and P-glycoprotein-mediated transport by trade herbal products. Basic Clin. Pharmacol. Toxicol., 2008, 102(5), 466-475.
[http://dx.doi.org/10.1111/j.1742-7843.2008.00227.x] [PMID: 18331390]
[85]
Müller, C.E.; Schumacher, B.; Brattström, A.; Abourashed, E.A.; Koetter, U. Interactions of valerian extracts and a fixed valerian-hop extract combination with adenosine receptors. Life Sci., 2002, 71(16), 1939-1949.
[http://dx.doi.org/10.1016/S0024-3205(02)01964-1] [PMID: 12175708]
[86]
Abourashed, E.A.; Koetter, U.; Brattström, A. In vitro binding experiments with a Valerian, hops and their fixed combination extract (Ze91019) to selected central nervous system receptors. Phytomedicine, 2004, 11(7-8), 633-638.
[http://dx.doi.org/10.1016/j.phymed.2004.03.005] [PMID: 15636177]
[87]
Ortiz, J.G.; Nieves-Natal, J.; Chavez, P. Effects of Valeriana officinalis extracts on [3H]flunitrazepam binding, synaptosomal [3H]GABA uptake, and hippocampal [3H]GABA release. Neurochem. Res., 1999, 24(11), 1373-1378.
[http://dx.doi.org/10.1023/A:1022576405534] [PMID: 10555777]
[88]
Cavadas, C.; Araújo, I.; Cotrim, M.D.; Amaral, T.; Cunha, A.P.; Macedo, T.; Ribeiro, C.F. In vitro study on the interaction of Valeriana officinalis L. extracts and their amino acids on GABAA receptor in rat brain. Arzneimittelforschung, 1995, 45(7), 753-755.
[PMID: 8573216]
[89]
Riedel, E.; Hänsel, R.; Ehrke, G. [Inhibition of gamma-aminobutyric acid catabolism by valerenic acid derivatives]. Planta Med., 1982, 46(4), 219-220.
[http://dx.doi.org/10.1055/s-2007-971218] [PMID: 7163416]
[90]
Benke, D.; Barberis, A.; Kopp, S.; Altmann, K-H.; Schubiger, M.; Vogt, K.E.; Rudolph, U.; Möhler, H. GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extracts. Neuropharmacology, 2009, 56(1), 174-181.
[http://dx.doi.org/10.1016/j.neuropharm.2008.06.013] [PMID: 18602406]
[91]
Santos, M.S.; Ferreira, F.; Cunha, A.P.; Carvalho, A.P.; Ribeiro, C.F.; Macedo, T. Synaptosomal GABA release as influenced by valerian root extract--involvement of the GABA carrier. Arch. Int. Pharmacodyn. Ther., 1994, 327(2), 220-231.
[PMID: 7979830]
[92]
Ortiz, J.G.; Rassi, N.; Maldonado, P.M.; González-Cabrera, S.; Ramos, I. Commercial valerian interactions with [3H]Flunitrazepam and [3H]MK-801 binding to rat synaptic membranes. Phytother. Res., 2006, 20(9), 794-798.
[http://dx.doi.org/10.1002/ptr.1960] [PMID: 16819753]
[93]
Nencini, C.; Cavallo, F.; Capasso, A.; De Feo, V.; De Martino, L.; Bruni, G.; Giorgi, G.; Micheli, L. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts. J. Ethnopharmacol., 2006, 108(2), 185-187.
[http://dx.doi.org/10.1016/j.jep.2006.04.027] [PMID: 16839726]
[94]
Alkharfy, K.M.; Frye, R.F. Effect of valerian, valerian/hops extracts, and valerenic acid on glucuronidation in vitro. Xenobiotica, 2007, 37(2), 113-123.
[http://dx.doi.org/10.1080/00498250601050420] [PMID: 17484515]
[95]
Hui-lian, W.; Dong-fang, Z.; Zhao-feng, L.; Yang, L.; Qian-rong, L.i.; Yu-zhen, W. In vitro study on the genotoxicity of dichloromethane extracts of valerian (DEV) in human endothelial ECV304 cells and the effect of vitamins E and C in attenuating the DEV-induced DNA damages. Toxicol. Appl. Pharmacol., 2003, 188(1), 36-41.
[http://dx.doi.org/10.1016/S0041-008X(03)00017-6] [PMID: 12668120]
[96]
Del Valle-Mojica, L.M.; Cordero-Hernández, J.M.; González-Medina, G.; Ramos-Vélez, I.; Berríos-Cartagena, N.; Torres-Hernández, B.A.; Ortíz, J.G. Aqueous and ethanolic Valeriana officinalis extracts change the binding of ligands to glutamate receptors. Evid. Based Complement. Alternat. Med., 2011, 2011891819
[http://dx.doi.org/10.1155/2011/891819] [PMID: 21151614]
[97]
Vo, L.T.; Chan, D.; King, R.G. Investigation of the effects of peppermint oil and valerian on rat liver and cultured human liver cells. Clin. Exp. Pharmacol. Physiol., 2003, 30(10), 799-804.
[http://dx.doi.org/10.1046/j.1440-1681.2003.03912.x] [PMID: 14516421]
[98]
Lin, S.; Shen, Y-H.; Li, H-L.; Yang, X-W.; Chen, T.; Lu, L-H.; Huang, Z-S.; Liu, R-H.; Xu, X-K.; Zhang, W-D.; Wang, H. Acylated iridoids with cytotoxicity from Valeriana jatamansi. J. Nat. Prod., 2009, 72(4), 650-655.
[http://dx.doi.org/10.1021/np800716f] [PMID: 19245261]
[99]
Bounthanh, C.; Bergmann, C.; Beck, J.P.; Haag-Berrurier, M.; Anton, R. Valepotriates, a new class of cytotoxic and antitumor agents. Planta Med., 1981, 41(1), 21-28.
[http://dx.doi.org/10.1055/s-2007-971668] [PMID: 7232547]
[100]
Bos, R.; Hendriks, H.; Scheffer, J.J.C.; Woerdenbag, H.J. Cytotoxic potential of valerian constituents and valerian tinctures. Phytomedicine, 1998, 5(3), 219-225.
[http://dx.doi.org/10.1016/S0944-7113(98)80032-9] [PMID: 23195845]
[101]
Tortarolo, M.; Braun, R.; Hubner, G.E.; Maurer, H.R. In vitro effects of epoxide-bearing valepotriates on mouse early Hematopoietic Progenitor cells and human lymphocytes-t. Arch. Toxicol., 1982, 51(1), 37-42.
[http://dx.doi.org/10.1007/BF00279319]
[102]
Bounthanh, C.; Richert, L.; Beck, J.P.; Haag-Berrurier, M.; Anton, R. The action of valepotriates on the synthesis of DNA and proteins of cultured hepatoma cells. Planta Med., 1983, 49(3), 138-142.
[http://dx.doi.org/10.1055/s-2007-969834] [PMID: 6657786]
[103]
Lin, S.; Chen, T.; Fu, P.; Ye, J.; Yang, X-W.; Shan, L.; Li, H-L.; Liu, R-H.; Shen, Y-H.; Xu, X-K.; Zhang, W.D. Three decomposition products of valepotriates from Valeriana jatamansi and their cytotoxic activity. J. Asian Nat. Prod. Res., 2015, 17(5), 455-461.
[http://dx.doi.org/10.1080/10286020.2015.1041933] [PMID: 25971678]
[104]
Lin, S.; Fu, P.; Chen, T.; Ye, J.; Yang, X.W.; Zhang, W.D. Three minor valepotriate isomers from Valeriana jatamansi and their cytotoxicity. J. Asian Nat. Prod. Res., 2017, 19(1), 15-21.
[http://dx.doi.org/10.1080/10286020.2016.1258065] [PMID: 27924641]
[105]
Glaser, J.; Schultheis, M.; Moll, H.; Hazra, B.; Holzgrabe, U. Antileishmanial and cytotoxic compounds from Valeriana wallichii and identification of a novel nepetolactone derivative. Molecules, 2015, 20(4), 5740-5753.
[http://dx.doi.org/10.3390/molecules20045740] [PMID: 25834987]
[106]
Ganta, K.K.; Mandal, A.; Debnath, S.; Hazra, B.; Chaubey, B. anti-hcv activity from semi-purified methanolic root extracts of Valeriana wallichii. Phytother. Res., 2017, 31(3), 433-440.
[http://dx.doi.org/10.1002/ptr.5765] [PMID: 28078810]
[107]
Wang, P.C.; Ran, X.H.; Luo, H.R.; Ma, Q.Y.; Zhou, J.; Hu, J.M.; Zhao, Y.X.; Volvalerine, A. Volvalerine A, an unprecedented N-containing sesquiterpenoid dimer derivative from Valeriana officinalis var. latifolia. Fitoterapia, 2016, 109, 174-178.
[http://dx.doi.org/10.1016/j.fitote.2016.01.003] [PMID: 26779941]
[108]
Torssell, K.; Wahlberg, K. Isolation, structure and synthesis of alkaloids from Valeriana officinalis L. Acta Chem. Scand., 1967, 21(1), 53-62.
[http://dx.doi.org/10.3891/acta.chem.scand.21-0053] [PMID: 4291658]
[109]
Balandrin, M.F. Commercial utilization of plant-derived saponins: an overview of medicinal, pharmaceutical, and industrial applications. Adv. Exp. Med. Biol., 1996, 404, 1-14.
[http://dx.doi.org/10.1007/978-1-4899-1367-8_1] [PMID: 8957279]
[110]
Mennini, P.; Bernasconi, P.; Bombardelli, E.; Morazzoni, P. In vitro study on the interaction of extracts and pure compounds from Valeriana officinalis roots with GABA, benzodiazepine, and barbiturate receptors in rat brain. Fitoterapia, 1993, 64, 291-300.
[111]
Sichardt, K.; Vissiennon, Z.; Koetter, U.; Brattström, A.; Nieber, K. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A(1)- and GABA(A)-receptors. Phytother. Res., 2007, 21(10), 932-937.
[http://dx.doi.org/10.1002/ptr.2197] [PMID: 17582590]
[112]
Estrada-Soto, S.; Rivera-Leyva, J.; Ramírez-Espinosa, J.J.; Castillo-España, P.; Aguirre-Crespo, F.; Hernández-Abreu, O. Vasorelaxant effect of Valeriana edulis ssp. procera (Valerianaceae) and its mode of action as calcium channel blocker. J. Pharm. Pharmacol., 2010, 62(9), 1167-1174.
[http://dx.doi.org/10.1111/j.2042-7158.2010.01146.x] [PMID: 20796196]
[113]
Piccinelli, A.L.; Arana, S.; Caceres, A.; di Villa Bianca, Rd.; Sorrentino, R.; Rastrelli, L. New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities. J. Nat. Prod., 2004, 67(7), 1135-1140.
[http://dx.doi.org/10.1021/np049879c] [PMID: 15270567]
[114]
Karadeniz, A.; Çinbilgel, I.; Gün, S.S.; Çetin, A. Antioxidant activity of some Turkish medicinal plants. Nat. Prod. Res., 2015, 29(24), 2308-2312.
[http://dx.doi.org/10.1080/14786419.2015.1005618] [PMID: 25649168]
[115]
Gilani, A.H.; Khan, A.U.; Jabeen, Q.; Subhan, F.; Ghafar, R. Antispasmodic and blood pressure lowering effects of Valeriana wallichii are mediated through K+ channel activation. J. Ethnopharmacol., 2005, 100(3), 347-352.
[http://dx.doi.org/10.1016/j.jep.2005.05.010] [PMID: 16002246]
[116]
Rosecrans, J.A.; Defeo, J.J.; Youngken, H.W., Jr Pharmacological investigation of certain Valeriana officinalis L. extracts. J. Pharm. Sci., 1961, 50(3), 240-244.
[http://dx.doi.org/10.1002/jps.2600500315] [PMID: 13743306]
[117]
Bos, R.; Woerdenbag, H.J.; Pras, N. Determination of valepotriates. J. Chromatogr. A, 2002, 967(1), 131-146.
[http://dx.doi.org/10.1016/S0021-9673(02)00036-5] [PMID: 12219926]
[118]
de Oliveria, D.M.; Barreto, G.; De Andrade, D.V.G.; Saraceno, E.; Aon-Bertolino, L.; Capani, F.; Dos Santos El Bachá, R.; Giraldez, L.D. Cytoprotective effect of Valeriana officinalis extract on an in vitro experimental model of Parkinson disease. Neurochem. Res., 2009, 34(2), 215-220.
[http://dx.doi.org/10.1007/s11064-008-9749-y] [PMID: 18512151]
[119]
Xu, J.; Guo, Y.; Xie, C.; Jin, D-Q.; Gao, J.; Gui, L. Isolation and neuroprotective activities of acylated iridoids from Valeriana jatamansi. Chem. Biodivers., 2012, 9(7), 1382-1388.
[http://dx.doi.org/10.1002/cbdv.201100238] [PMID: 22782884]
[120]
Dong, F-W.; Wu, Z-K.; Yang, L.; Zi, C-T.; Yang, D.; Ma, R-J.; Liu, Z-H.; Luo, H-R.; Zhou, J.; Hu, J-M. Iridoids and sesquiterpenoids of Valeriana stenoptera and their effects on NGF-induced neurite outgrowth in PC12 cells. Phytochemistry, 2015, 118, 51-60.
[http://dx.doi.org/10.1016/j.phytochem.2015.08.015] [PMID: 26343415]
[121]
von der Hude, W.; Scheutwinkel-Reich, M.; Braun, R. Bacterial mutagenicity of the tranquilizing constituents of Valerianaceae roots. Mutat. Res., 1986, 169(1-2), 23-27.
[http://dx.doi.org/10.1016/0165-1218(86)90013-3] [PMID: 3511364]
[122]
Khuda, F.; Iqbal, Z.; Zakiullah, ; Khan, A.; Nasir, F. Antimicrobial and anti-inflammatory activities of leaf extract of Valeriana wallichii DC. Pak. J. Pharm. Sci., 2012, 25(4), 715-719.
[PMID: 23009985]
[123]
Khuda, F.; Iqbal, Z.; Khan, A.; Zakiullah, ; Nasir, F.; Shah, Y. Anti-inflammatory activity of the topical preparation of Valeriana wallichii and Achyranthes aspera leaves. Pak. J. Pharm. Sci., 2013, 26(3), 451-454.
[PMID: 23625416]
[124]
Spinella, M. Herbal medicines and epilepsy: The potential for benefit and adverse effects. Epilepsy Behav., 2001, 2(6), 524-532.
[http://dx.doi.org/10.1006/ebeh.2001.0281] [PMID: 12609386]
[125]
Colalto, C. Herbal interactions on absorption of drugs: Mechanisms of action and clinical risk assessment. Pharmacol. Res., 2010, 62(3), 207-227.
[http://dx.doi.org/10.1016/j.phrs.2010.04.001] [PMID: 20399862]
[126]
Murakami, N.; Ye, Y.; Kawanishi, M.; Aoki, S.; Kudo, N.; Yoshida, M.; Nakayama, E.E.; Shioda, T.; Kobayashi, M. New Rev-transport inhibitor with anti-HIV activity from Valerianae Radix. Bioorg. Med. Chem. Lett., 2002, 12(20), 2807-2810.
[http://dx.doi.org/10.1016/S0960-894X(02)00624-8] [PMID: 12270151]
[127]
Kim, J.; Seo, S-M.; Lee, S-G.; Shin, S-C.; Park, I-K. Nematicidal activity of plant essential oils and components from coriander (Coriandrum sativum), Oriental sweetgum (Liquidambar orientalis), and valerian (Valeriana wallichii) essential oils against pine wood nematode (Bursaphelenchus xylophilus). J. Agric. Food Chem., 2008, 56(16), 7316-7320.
[http://dx.doi.org/10.1021/jf800780f] [PMID: 18605734]
[128]
Ghosh, S.; Debnath, S.; Hazra, S.; Hartung, A.; Thomale, K.; Schultheis, M.; Kapkova, P.; Schurigt, U.; Moll, H.; Holzgrabe, U.; Hazra, B. Valeriana wallichii root extracts and fractions with activity against Leishmania spp. Parasitol. Res., 2011, 108(4), 861-871.
[http://dx.doi.org/10.1007/s00436-010-2127-0] [PMID: 21085992]
[129]
Sudati, J.H.; Fachinetto, R.; Pereira, R.P.; Boligon, A.A.; Athayde, M.L.; Soares, F.A.; de Vargas Barbosa, N.B.; Rocha, J.B. In vitro antioxidant activity of Valeriana officinalis against different neurotoxic agents. Neurochem. Res., 2009, 34(8), 1372-1379.
[http://dx.doi.org/10.1007/s11064-009-9917-8] [PMID: 19191025]
[130]
Wang, F.; Zhang, Y.; Wu, S.; He, Y.; Dai, Z.; Ma, S.; Liu, B. Studies of the structure-antioxidant activity relationships and antioxidant activity mechanism of iridoid valepotriates and their degradation products. PLoS One, 2017, 12(12)e0189198
[http://dx.doi.org/10.1371/journal.pone.0189198] [PMID: 29232391]
[131]
Santos, G.; Giraldez-Alvarez, L.D.; Ávila-Rodriguez, M.; Capani, F.; Galembeck, E.; Neto, A.G.; Barreto, G.E.; Andrade, B. SUR1 Receptor Interaction with Hesperidin and Linarin Predicts Possible Mechanisms of Action of Valeriana officinalis in Parkinson. Front. Aging Neurosci., 2016, 8, 97.
[http://dx.doi.org/10.3389/fnagi.2016.00097] [PMID: 27199743]
[132]
Aralbaeva, A.N.; Mamataeva, A.T.; Zhaparkulova, N.I.; Utegalieva, R.S.; Khanin, M.; Danilenko, M.; Murzakhmetova, M.K. A composition of medicinal plants with an enhanced ability to suppress microsomal lipid peroxidation and a protective activity against carbon tetrachloride-induced hepatotoxicity. Biomed. Pharmacother., 2017, 96, 1283-1291.
[http://dx.doi.org/10.1016/j.biopha.2017.11.085] [PMID: 29169731]
[133]
Sharifzadeh, M.; Hadjiakhoondi, A.; Khanavi, M.; Susanabadi, M. Effects of aqueous, methanolic and chloroform extracts of rhizome and aerial parts of Valeriana officinalis L. on naloxone-induced jumping in morphine-dependent mice. Addict. Biol., 2006, 11(2), 145-151.
[http://dx.doi.org/10.1111/j.1369-1600.2006.00016.x] [PMID: 16800827]
[134]
Jung, H.Y.; Yoo, D.Y.; Kim, W.; Nam, S.M.; Kim, J.W.; Choi, J.H.; Kwak, Y.G.; Yoon, Y.S.; Hwang, I.K. Valeriana officinalis root extract suppresses physical stress by electric shock and psychological stress by nociceptive stimulation-evoked responses by decreasing the ratio of monoamine neurotransmitters to their metabolites. BMC Complement. Altern. Med., 2014, 14, 476.
[http://dx.doi.org/10.1186/1472-6882-14-476] [PMID: 25495725]
[135]
Yoo, D.Y.; Jung, H.Y.; Nam, S.M.; Kim, J.W.; Choi, J.H.; Kwak, Y.G.; Yoo, M.; Lee, S.; Yoon, Y.S.; Hwang, I.K. Valeriana officinalis Extracts Ameliorate Neuronal Damage by Suppressing Lipid Peroxidation in the Gerbil Hippocampus Following Transient Cerebral Ischemia. J. Med. Food, 2015, 18(6), 642-647.
[http://dx.doi.org/10.1089/jmf.2014.3295] [PMID: 25785762]
[136]
Andreatini, R.; Leite, J.R. Effect of valepotriates on the behavior of rats in the elevated plus-maze during diazepam withdrawal. Eur. J. Pharmacol., 1994, 260(2-3), 233-235.
[http://dx.doi.org/10.1016/0014-2999(94)90342-5] [PMID: 7988648]
[137]
Andreatini, R.; Sartori, V.A.; Seabra, M.L.V.; Leite, J.R. Effect of valepotriates (valerian extract) in generalized anxiety disorder: a randomized placebo-controlled pilot study. Phytother. Res., 2002, 16(7), 650-654.
[http://dx.doi.org/10.1002/ptr.1027] [PMID: 12410546]
[138]
Murphy, K.; Kubin, Z.J.; Shepherd, J.N.; Ettinger, R.H. Valeriana officinalis root extracts have potent anxiolytic effects in laboratory rats. Phytomedicine, 2010, 17(8-9), 674-678.
[http://dx.doi.org/10.1016/j.phymed.2009.10.020] [PMID: 20042323]
[139]
You, J-S.; Peng, M.; Shi, J-L.; Zheng, H-Z.; Liu, Y.; Zhao, B-S.; Guo, J-Y. Evaluation of anxiolytic activity of compound Valeriana jatamansi Jones in mice. BMC Complement. Altern. Med., 2012, 12, 223.
[http://dx.doi.org/10.1186/1472-6882-12-223] [PMID: 23171285]
[140]
Hiller, K.O.; Zetler, G. Neuropharmacological studies on ethanol extracts of Valeriana officinalis L: Behavioural and anticonvulsant properties. Phytother. Res., 1996, 10(2), 145-151.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199603)10:2<145:AID-PTR793>3.0.CO;2-W]
[141]
Rezvani, M.E.; Roohbakhsh, A.; Allahtavakoli, M.; Shamsizadeh, A. Anticonvulsant effect of aqueous extract of Valeriana officinalis in amygdala-kindled rats: possible involvement of adenosine. J. Ethnopharmacol., 2010, 127(2), 313-318.
[http://dx.doi.org/10.1016/j.jep.2009.11.002] [PMID: 19900527]
[142]
Felgentreff, F.; Becker, A.; Meier, B.; Brattström, A. Valerian extract characterized by high valerenic acid and low acetoxy valerenic acid contents demonstrates anxiolytic activity. Phytomedicine, 2012, 19(13), 1216-1222.
[http://dx.doi.org/10.1016/j.phymed.2012.08.003] [PMID: 22944521]
[143]
Leuschner, J.; Muller, J.; Rudmann, M. characterization of the central nervous de-pressant activity of a commercially availa-ble valerian root extract Arzneimittel-Forschung/Drug Research, 1993, 43-1(6), 638-641.
[144]
Tokunaga, S.; Takeda, Y.; Niimoto, T.; Nishida, N.; Kubo, T.; Ohno, T.; Matsuura, Y.; Kawahara, Y.; Shinomiya, K.; Kamei, C. Effect of valerian extract preparation (BIM) on the sleep-wake cycle in rats. Biol. Pharm. Bull., 2007, 30(2), 363-366.
[http://dx.doi.org/10.1248/bpb.30.363] [PMID: 17268081]
[145]
Sahu, S.; Ray, K.; Yogendra Kumar, M.S.; Gupta, S.; Kauser, H.; Kumar, S.; Mishra, K.; Panjwani, U. Valeriana wallichii root extract improves sleep quality and modulates brain monoamine level in rats. Phytomedicine, 2012, 19(10), 924-929.
[http://dx.doi.org/10.1016/j.phymed.2012.05.005] [PMID: 22766307]
[146]
Müller, L.G.; Salles, L.A.; Stein, A.C.; Betti, A.H.; Sakamoto, S.; Cassel, E.; Vargas, R.F.; von Poser, G.L.; Rates, S.M. Antidepressant-like effect of Valeriana glechomifolia Meyer (Valerianaceae) in mice. Prog. Neuropsychopharmacol. Biol. Psychiatry, 2012, 36(1), 101-109.
[http://dx.doi.org/10.1016/j.pnpbp.2011.08.015] [PMID: 21889562]
[147]
Müller, L.G.; Borsoi, M.; Stolz, E.D.; Herzfeldt, V.; Viana, A.F.; Ravazzolo, A.P.; Rates, S.M. Diene Valepotriates from Valeriana glechomifolia Prevent Lipopolysaccharide-Induced Sickness and Depressive-Like Behavior in Mice. Evid. Based Complement. Alternat. Med., 2015, 2015145914
[http://dx.doi.org/10.1155/2015/145914] [PMID: 26170871]
[148]
Sah, S.P.; Mathela, C.S.; Chopra, K. Antidepressant effect of Valeriana wallichii patchouli alcohol chemotype in mice: Behavioural and biochemical evidence. J. Ethnopharmacol., 2011, 135(1), 197-200.
[http://dx.doi.org/10.1016/j.jep.2011.02.018] [PMID: 21354297]
[149]
Sah, S.P.; Mathela, C.S.; Chopra, K. Involvement of nitric oxide (NO) signalling pathway in the antidepressant activity of essential oil of Valeriana wallichii Patchouli alcohol chemotype. Phytomedicine, 2011, 18(14), 1269-1275.
[http://dx.doi.org/10.1016/j.phymed.2011.06.009] [PMID: 21795033]
[150]
Oshima, Y.; Matsuoka, S.; Ohizumi, Y. Antidepressant principles of Valeriana fauriei roots. Chem. Pharm. Bull. (Tokyo), 1995, 43(1), 169-170.
[http://dx.doi.org/10.1248/cpb.43.169] [PMID: 7895306]
[151]
Liu, X.G.; Gao, P.Y.; Wang, G.S.; Song, S.J.; Li, L.Z.; Li, X.; Yao, X.S.; Zhang, Z.X. In vivo antidepressant activity of sesquiterpenes from the roots of Valeriana fauriei Briq. Fitoterapia, 2012, 83(3), 599-603.
[http://dx.doi.org/10.1016/j.fitote.2012.01.004] [PMID: 22285939]
[152]
Subhan, F.; Karim, N.; Gilani, A.H.; Sewell, R.D.E. Terpenoid content of Valeriana wallichii extracts and antidepressant-like response profiles. Phytother. Res., 2010, 24(5), 686-691.
[PMID: 19943315]
[153]
Hattesohl, M.; Feistel, B.; Sievers, H.; Lehnfeld, R.; Hegger, M.; Winterhoff, H. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties. Phytomedicine, 2008, 15(1-2), 2-15.
[http://dx.doi.org/10.1016/j.phymed.2007.11.027] [PMID: 18160026]
[154]
Sridharan, S.; Mohankumar, K.; Jeepipalli, S.P.; Sankaramourthy, D.; Ronsard, L.; Subramanian, K.; Thamilarasan, M.; Raja, K.; Chandra, V.K.; Sadras, S.R. Neuroprotective effect of Valeriana wallichii rhizome extract against the neurotoxin MPTP in C57BL/6 mice. Neurotoxicology, 2015, 51, 172-183.
[http://dx.doi.org/10.1016/j.neuro.2015.10.012] [PMID: 26522450]
[155]
Capasso, A.; DeFeo, V.; DeSimone, F.; Sorrentino, L. Pharmacological effects of aqueous extract from Valeriana adscendens. Phytother. Res., 1996, 10(4), 309-312.
[http://dx.doi.org/10.1002/(SICI)1099-1573(199606)10:4<309:AID-PTR850>3.0.CO;2-J]
[156]
Thies, P.W.; Funke, S. [On the active ingredients in baldrian. 1. Detection and isolation of isovalerian acid esters with sedative effect from roots and rhizomes of various valerian and kentranthus species]. Tetrahedron Lett., 1966, 11, 1155-1162.
[http://dx.doi.org/10.1016/S0040-4039(00)72388-4] [PMID: 5964248]
[157]
Medina, J.H.; Peña, C.; Levi de Stein, M.; Wolfman, C.; Paladini, A.C. Benzodiazepine-like molecules, as well as other ligands for the brain benzodiazepine receptors, are relatively common constituents of plants. Biochem. Biophys. Res. Commun., 1989, 165(2), 547-553.
[http://dx.doi.org/10.1016/S0006-291X(89)80001-4] [PMID: 2557016]
[158]
Yao, M.; Ritchie, H.E.; Brown-Woodman, P.D. A developmental toxicity-screening test of valerian. J. Ethnopharmacol., 2007, 113(2), 204-209.
[http://dx.doi.org/10.1016/j.jep.2007.05.028] [PMID: 17611059]
[159]
Mkrtchyan, A.; Panosyan, V.; Panossian, A.; Wikman, G.; Wagner, H. A phase I clinical study of Andrographis paniculata fixed combination Kan Jang versus ginseng and valerian on the semen quality of healthy male subjects. Phytomedicine, 2005, 12(6-7), 403-409.
[http://dx.doi.org/10.1016/j.phymed.2004.10.004] [PMID: 16008115]
[160]
Tufik, S.; Fujita, K.; Seabra, Mde.L.; Lobo, L.L. Effects of a prolonged administration of valepotriates in rats on the mothers and their offspring. J. Ethnopharmacol., 1994, 41(1-2), 39-44.
[http://dx.doi.org/10.1016/0378-8741(94)90055-8] [PMID: 8170157]
[161]
Al-Majed, A.A.; Al-Yahya, A.A.; Al-Bekairi, A.M.; Al-Shabanah, O.A.; Qureshi, S. Studies on the cytological and biochemical effects of valerian in somatic and germ cells of Swiss albino mice. Food Chem. Toxicol., 2006, 44(11), 1830-1837.
[http://dx.doi.org/10.1016/j.fct.2006.06.001] [PMID: 16879905]
[162]
Kakehashi, A.; Kato, A.; Ishii, N.; Wei, M.; Morimura, K.; Fukushima, S.; Wanibuchi, H. Valerian inhibits rat hepatocarcinogenesis by activating GABA(A) receptor-mediated signaling. PLoS One, 2014, 9(11)e113610
[http://dx.doi.org/10.1371/journal.pone.0113610] [PMID: 25419570]
[163]
Zhu, J.; Xu, K.; Zhang, X.; Cao, J.; Jia, Z.; Yang, R.; Ma, C.; Chen, C.; Zhang, T.; Yan, Z. Studies on the regulation of lipid metabolism and its mechanism of the iridoids rich fraction in Valeriana jatamansi Jones. Biomed. Pharmacother., 2016, 84, 1891-1898.
[http://dx.doi.org/10.1016/j.biopha.2016.10.099] [PMID: 27832992]
[164]
Lee, H.; Won, H.; Im, J.; Kim, Y.O.; Lee, S.; Cho, I.H.; Kim, H.K.; Kwon, J.T.; Kim, H.J. Effect of Valeriana fauriei extract on the offspring of adult rats exposed to prenatal stress. Int. J. Mol. Med., 2016, 38(1), 251-258.
[http://dx.doi.org/10.3892/ijmm.2016.2589] [PMID: 27220809]
[165]
Torres-Hernández, B.A.; Colón, L.R.; Rosa-Falero, C.; Torrado, A.; Miscalichi, N.; Ortíz, J.G.; González-Sepúlveda, L.; Pérez-Ríos, N.; Suárez-Pérez, E.; Bradsher, J.N.; Behra, M. Reversal of pentylenetetrazole-altered swimming and neural activity-regulated gene expression in zebrafish larvae by valproic acid and valerian extract. Psychopharmacology (Berl.), 2016, 233(13), 2533-2547.
[http://dx.doi.org/10.1007/s00213-016-4304-z] [PMID: 27165438]
[166]
Choi, H.S.; Ko, B.S.; Kim, H.D.; Hong, K.B.; Suh, H.J. Effect of Valerian/Hop Mixture on Sleep-Related Behaviors in Drosophila melanogaster. Biol. Pharm. Bull., 2017, 40(7), 1101-1110.
[http://dx.doi.org/10.1248/bpb.b17-00262] [PMID: 28674253]
[167]
Müller, L.G.; Salles, L.; Lins, H.A.; Feijó, P.R.; Cassel, E.; Vargas, R.; von Poser, G.L.; Noël, F.; Quintas, L.E.; Rates, S.M. Effects of diene valepotriates from Valeriana glechomifolia on Na+/K+-ATPase activity in the cortex and hippocampus of mice. Planta Med., 2015, 81(3), 200-207.
[http://dx.doi.org/10.1055/s-0034-1396200] [PMID: 25615276]
[168]
Kupfer, D.J.; Reynolds, C.F., III Management of insomnia. N. Engl. J. Med., 1997, 336(5), 341-346.
[http://dx.doi.org/10.1056/NEJM199701303360506] [PMID: 9011788]
[169]
Dimpfel, W.; Suter, A. Sleep improving effects of a single dose administration of a valerian/hops fluid extract - a double blind, randomized, placebo-controlled sleep-EEG study in a parallel design using electrohypnograms. Eur. J. Med. Res., 2008, 13(5), 200-204.
[http://dx.doi.org/10.1055/s-2008-1047853] [PMID: 18559301]
[170]
Holbrook, A.M.; Crowther, R.; Lotter, A.; Cheng, C.; King, D. The diagnosis and management of insomnia in clinical practice: a practical evidence-based approach. CMAJ Can. Med. Assoc. J., 2000, 162(2), 216-220.
[171]
Bega, D.; Malkani, R. Alternative treatment of restless legs syndrome: an overview of the evidence for mind-body interventions, lifestyle interventions, and neutraceuticals. Sleep Med., 2016, 17, 99-105.
[http://dx.doi.org/10.1016/j.sleep.2015.09.009] [PMID: 26847981]
[172]
O’Hara, M.; Kiefer, D.; Farrell, K.; Kemper, K. A review of 12 commonly used medicinal herbs. Arch. Fam. Med., 1998, 7(6), 523-536.
[http://dx.doi.org/10.1001/archfami.7.6.523] [PMID: 9821826]
[173]
Bent, S.; Padula, A.; Moore, D.; Patterson, M.; Mehling, W. Valerian for sleep: a systematic review and meta-analysis. Am. J. Med., 2006, 119(12), 1005-1012.
[http://dx.doi.org/10.1016/j.amjmed.2006.02.026] [PMID: 17145239]
[174]
France, K.G.; McLay, L.K.; Hunter, J.E.; France, M.L.S. Empirical research evaluating the effects of non-traditional approaches to enhancing sleep in typical and clinical children and young people. Sleep Med. Rev., 2018, 39, 69-81.
[http://dx.doi.org/10.1016/j.smrv.2017.07.004] [PMID: 28918314]
[175]
Leathwood, P.D.; Chauffard, F.; Heck, E.; Munoz-Box, R. Aqueous extract of valerian root (Valeriana officinalis L.) improves sleep quality in man. Pharmacol. Biochem. Behav., 1982, 17(1), 65-71.
[http://dx.doi.org/10.1016/0091-3057(82)90264-7] [PMID: 7122669]
[176]
Leathwood, P.D.; Chauffard, F. Aqueous extract of valerian reduces latency to fall asleep in man. Planta Med., 1985, (2), 144-148.
[http://dx.doi.org/10.1055/s-2007-969430] [PMID: 4034730]
[177]
Balderer, G.; Borbély, A.A. Effect of valerian on human sleep. Psychopharmacology (Berl.), 1985, 87(4), 406-409.
[http://dx.doi.org/10.1007/BF00432503] [PMID: 3936097]
[178]
Donath, F.; Quispe, S.; Diefenbach, K.; Maurer, A.; Fietze, I.; Roots, I. Critical evaluation of the effect of valerian extract on sleep structure and sleep quality. Pharmacopsychiatry, 2000, 33(2), 47-53.
[http://dx.doi.org/10.1055/s-2000-7972] [PMID: 10761819]
[179]
Circosta, C.; De Pasquale, R.; Samperi, S.; Pino, A.; Occhiuto, F. Biological and analytical characterization of two extracts from Valeriana officinalis. J. Ethnopharmacol., 2007, 112(2), 361-367.
[http://dx.doi.org/10.1016/j.jep.2007.03.021] [PMID: 17467210]
[180]
Occhiuto, F.; Pino, A.; Palumbo, D.R.; Samperi, S.; De Pasquale, R.; Sturlese, E.; Circosta, C. Relaxing effects of Valeriana officinalis extracts on isolated human non-pregnant uterine muscle. J. Pharm. Pharmacol., 2009, 61(2), 251-256.
[http://dx.doi.org/10.1211/jpp.61.02.0016] [PMID: 19178774]
[181]
Morris, C.A.; Avorn, J. Internet marketing of herbal products. JAMA, 2003, 290(11), 1505-1509.
[http://dx.doi.org/10.1001/jama.290.11.1505] [PMID: 13129992]
[182]
Plushner, S.L. Valerian: Valeriana officinalis. Am. J. Health Syst. Pharm., 2000, 57(4) 328-333, 335 .
[183]
Mirabi, P.; Mojab, F. The effects of valerian root on hot flashes in menopausal women. Iran. J. Pharm. Res., 2013, 12(1), 217-222.
[PMID: 24250592]
[184]
Taavoni, S.; Nazem Ekbatani, N.; Haghani, H. Valerian/lemon balm use for sleep disorders during menopause. Complement. Ther. Clin. Pract., 2013, 19(4), 193-196.
[http://dx.doi.org/10.1016/j.ctcp.2013.07.002] [PMID: 24199972]
[185]
Taavoni, S.; Ekbatani, N.; Kashaniyan, M.; Haghani, H. Effect of valerian on sleep quality in postmenopausal women: a randomized placebo-controlled clinical trial. Menopause, 2011, 18(9), 951-955.
[http://dx.doi.org/10.1097/gme.0b013e31820e9acf] [PMID: 21775910]
[186]
Ghazanfarpour, M.; Sadeghi, R.; Abdolahian, S.; Latifnejad Roudsari, R. The efficacy of Iranian herbal medicines in alleviating hot flashes: A systematic review. Int. J. Reprod. Biomed. (Yazd), 2016, 14(3), 155-166.
[http://dx.doi.org/10.29252/ijrm.14.3.155] [PMID: 27294213]
[187]
Cropley, M.; Cave, Z.; Ellis, J.; Middleton, R.W. Effect of kava and valerian on human physiological and psychological responses to mental stress assessed under laboratory conditions. Phytother. Res., 2002, 16(1), 23-27.
[http://dx.doi.org/10.1002/ptr.1002] [PMID: 11807960]
[188]
Gutierrez, S.; Ang-Lee, M.K.; Walker, D.J.; Zacny, J.P. Assessing subjective and psychomotor effects of the herbal medication valerian in healthy volunteers. Pharmacol. Biochem. Behav., 2004, 78(1), 57-64.
[http://dx.doi.org/10.1016/j.pbb.2004.02.011] [PMID: 15159134]
[189]
Barton, D.L.; Atherton, P.J.; Bauer, B.A.; Moore, D.F., Jr; Mattar, B.I.; Lavasseur, B.I.; Rowland, K.M., Jr; Zon, R.T.; Lelindqwister, N.A.; Nagargoje, G.G.; Morgenthaler, T.I.; Sloan, J.A.; Loprinzi, C.L. The use of Valeriana officinalis (Valerian) in improving sleep in patients who are undergoing treatment for cancer: a phase III randomized, placebo-controlled, double-blind study (NCCTG Trial, N01C5). J. Support. Oncol., 2011, 9(1), 24-31.
[http://dx.doi.org/10.1016/j.suponc.2010.12.008] [PMID: 21399726]
[190]
Mirabi, P.; Dolatian, M.; Mojab, F.; Majd, H.A. Effects of valerian on the severity and systemic manifestations of dysmenorrhea. Int. J. Gynaecol. Obstet., 2011, 115(3), 285-288.
[http://dx.doi.org/10.1016/j.ijgo.2011.06.022] [PMID: 21959068]
[191]
Müller, D.; Pfeil, T.; von den Driesch, V. Treating depression comorbid with anxiety--results of an open, practice-oriented study with St John’s wort WS 5572 and valerian extract in high doses. Phytomedicine, 2003, 10(Suppl. 4), 25-30.
[http://dx.doi.org/10.1078/1433-187X-00305] [PMID: 12807339]
[192]
Wrighton, S.A.; Schuetz, E.G.; Thummel, K.E.; Shen, D.D.; Korzekwa, K.R.; Watkins, P.B. The human CYP3A subfamily: practical considerations. Drug Metab. Rev., 2000, 32(3-4), 339-361.
[http://dx.doi.org/10.1081/DMR-100102338] [PMID: 11139133]
[193]
Raimundo, S.; Fischer, J.; Eichelbaum, M.; Griese, E.U.; Schwab, M.; Zanger, U.M. Elucidation of the genetic basis of the common ‘intermediate metabolizer’ phenotype for drug oxidation by CYP2D6. Pharmacogenetics, 2000, 10(7), 577-581.
[http://dx.doi.org/10.1097/00008571-200010000-00001] [PMID: 11037799]
[194]
Burk, O.; Wojnowski, L. Cytochrome P450 3A and their regulation. Naunyn Schmiedebergs Arch. Pharmacol., 2004, 369(1), 105-124.
[http://dx.doi.org/10.1007/s00210-003-0815-3] [PMID: 14569421]
[195]
Skórska, C.; Golec, M.; Mackiewicz, B.; Góra, A.; Dutkiewicz, J. Health effects of exposure to herb dust in valerian growing farmers. Ann. Agric. Environ. Med., 2005, 12(2), 247-252.
[PMID: 16457481]
[196]
Taibi, D.M.; Landis, C.A.; Petry, H.; Vitiello, M.V. A systematic review of valerian as a sleep aid: safe but not effective. Sleep Med. Rev., 2007, 11(3), 209-230.
[http://dx.doi.org/10.1016/j.smrv.2007.03.002] [PMID: 17517355]
[197]
Ziegler, G.; Ploch, M.; Miettinen-Baumann, A.; Collet, W. Efficacy and tolerability of valerian extract LI 156 compared with oxazepam in the treatment of non-organic insomnia--a randomized, double-blind, comparative clinical study. Eur. J. Med. Res., 2002, 7(11), 480-486.
[PMID: 12568976]
[198]
Savage, K.; Firth, J.; Stough, C.; Sarris, J. GABA-modulating phytomedicines for anxiety: A systematic review of preclinical and clinical evidence. Phytother. Res., 2018, 32(1), 3-18.
[http://dx.doi.org/10.1002/ptr.5940] [PMID: 29168225]
[199]
Ang-Lee, M.K.; Moss, J.; Yuan, C.S. Herbal medicines and perioperative care. JAMA, 2001, 286(2), 208-216.
[http://dx.doi.org/10.1001/jama.286.2.208] [PMID: 11448284]
[200]
Garges, H.P.; Varia, I.; Doraiswamy, P.M. Cardiac complications and delirium associated with valerian root withdrawal. JAMA, 1998, 280(18), 1566-1567.
[http://dx.doi.org/10.1001/jama.280.18.1566-a] [PMID: 9820254]
[201]
Stevinson, C.; Ernst, E. Valerian for insomnia: a systematic review of randomized clinical trials. Sleep Med., 2000, 1(2), 91-99.
[http://dx.doi.org/10.1016/S1389-9457(99)00015-5] [PMID: 10767649]
[202]
Carrasco, M.C.; Vallejo, J.R.; Pardo-de-Santayana, M.; Peral, D.; Martín, M.A.; Altimiras, J. Interactions of Valeriana officinalis L. and Passiflora incarnata L. in a patient treated with lorazepam. Phytother. Res., 2009, 23(12), 1795-1796.
[http://dx.doi.org/10.1002/ptr.2847] [PMID: 19441067]
[203]
Kuhlmann, J.; Berger, W.; Podzuweit, H.; Schmidt, U. The influence of valerian treatment on “reaction time, alertness and concentration” in volunteers. Pharmacopsychiatry, 1999, 32(6), 235-241.
[http://dx.doi.org/10.1055/s-2007-991100] [PMID: 10599933]
[204]
Hadley, S.; Petry, J.J. Valerian. Am. Fam. Physician, 2003, 67(8), 1755-1758.
[PMID: 12725454]
[205]
Diaper, A.; Hindmarch, I. A double-blind, placebo-controlled investigation of the effects of two doses of a valerian preparation on the sleep, cognitive and psychomotor function of sleep-disturbed older adults. Phytother. Res., 2004, 18(10), 831-836.
[http://dx.doi.org/10.1002/ptr.1574] [PMID: 15551388]
[206]
Hobbs, C. Feverfew - A Literature Review. Herbal-Gram, 1989, 20, 26-35.
[207]
Gyllenhaal, C.; Merritt, S.L.; Peterson, S.D.; Block, K.I.; Gochenour, T. Efficacy and safety of herbal stimulants and sedatives in sleep disorders. Sleep Med. Rev., 2000, 4(3), 229-251.
[http://dx.doi.org/10.1053/smrv.1999.0093] [PMID: 12531167]
[208]
Kia, Y.H.; Alexander, S.; Dowling, D.; Standish, R. A case of steroid-responsive valerian-associated hepatitis. Intern. Med. J., 2016, 46(1), 118-119.
[http://dx.doi.org/10.1111/imj.12952] [PMID: 26813905]
[209]
Morin, A.K.; Jarvis, C.I.; Lynch, A.M. Therapeutic options for sleep-maintenance and sleep-onset insomnia. Pharmacotherapy, 2007, 27(1), 89-110.
[http://dx.doi.org/10.1592/phco.27.1.89] [PMID: 17192164]
[210]
Takeshita, S.; Takeshita, J. A case of hyponatremia due to self-treatment of anxiety with a beverage containing valerian root. Prim.Care Companion CNS Disord., , 2013. 15(1) PCC.12l01482.
[http://dx.doi.org/10.4088/PCC.12l01482]
[211]
Gardner, Z.; McGuffin, M. American Herbal Products Association’s Botanical Safety Handbook, 2nd ed; Taylor & Francis, 2013.
[212]
Brinker, F.J. Herb contraindications and drug interactions: with appendices addressing specific conditions and medicines; Eclectic Medical Publications, 1998.
[213]
Anderson, G.D.; Elmer, G.W.; Kantor, E.D.; Templeton, I.E.; Vitiello, M.V. Pharmacokinetics of valerenic acid after administration of valerian in healthy subjects. Phytother. Res., 2005, 19(9), 801-803.
[http://dx.doi.org/10.1002/ptr.1742] [PMID: 16220575]
[214]
Anderson, G.D.; Elmer, G.W.; Taibi, D.M.; Vitiello, M.V.; Kantor, E.; Kalhorn, T.F.; Howald, W.N.; Barsness, S.; Landis, C.A. Pharmacokinetics of valerenic acid after single and multiple doses of valerian in older women. Phytother. Res., 2010, 24(10), 1442-1446.
[http://dx.doi.org/10.1002/ptr.3151] [PMID: 20878691]
[215]
Bagge, A.; Schött, U.; Kander, T. Effects of naturopathic medicines on Multiplate and ROTEM: a prospective experimental pilot study in healthy volunteers. BMC Complement. Altern. Med., 2016, 16, 64.
[http://dx.doi.org/10.1186/s12906-016-1051-y] [PMID: 26887420]
[216]
Gromball, J.; Beschorner, F.; Wantzen, C.; Paulsen, U.; Burkart, M. Hyperactivity, concentration difficulties and impulsiveness improve during seven weeks’ treatment with valerian root and lemon balm extracts in primary school children. Phytomedicine, 2014, 21(8-9), 1098-1103.
[217]
Jenabi, E.; Shobeiri, F.; Hazavehei, S.M.M.; Roshanaei, G. The effect of Valerian on the severity and frequency of hot flashes: A triple-blind randomized clinical trial. Women Health, 2018, 58(3), 297-304.
[http://dx.doi.org/10.1080/03630242.2017.1296058] [PMID: 28278010]
[218]
Behboodi Moghadam, Z.; Rezaei, E.; Shirood Gholami, R.; Kheirkhah, M.; Haghani, H. The effect of Valerian root extract on the severity of pre menstrual syndrome symptoms. J. Tradit. Complement. Med., 2016, 6(3), 309-315.
[http://dx.doi.org/10.1016/j.jtcme.2015.09.001] [PMID: 27419099]
[219]
Ahmadi, M.; Khalili, H.; Abbasian, L.; Ghaeli, P. Effect of Valerian in Preventing Neuropsychiatric Adverse Effects of Efavirenz in HIV-Positive Patients: A Pilot Randomized, Placebo-Controlled Clinical Trial. Ann. Pharmacother., 2017, 51(6), 457-464.
[http://dx.doi.org/10.1177/1060028017696105] [PMID: 28478716]
[220]
Ross, S.M. Sleep disorders: a single dose administration of valerian/hops fluid extract (dormeasan) is found to be effective in improving sleep. Holist. Nurs. Pract., 2009, 23(4), 253-256.
[http://dx.doi.org/10.1097/HNP.0b013e3181aed09d] [PMID: 19574763]
[221]
Taibi, D.M.; Vitiello, M.V.; Barsness, S.; Elmer, G.W.; Anderson, G.D.; Landis, C.A. A randomized clinical trial of valerian fails to improve self-reported, polysomnographic, and actigraphic sleep in older women with insomnia. Sleep Med., 2009, 10(3), 319-328.
[http://dx.doi.org/10.1016/j.sleep.2008.02.001] [PMID: 18482867]
[222]
Waldschütz, R.; Klein, P. The homeopathic preparation Neurexan vs. valerian for the treatment of insomnia: an observational study. ScientificWorldJournal, 2008, 8, 411-420.
[http://dx.doi.org/10.1100/tsw.2008.61] [PMID: 18454251]
[223]
Oxman, A.D.; Flottorp, S.; Håvelsrud, K.; Fretheim, A.; Odgaard-Jensen, J.; Austvoll-Dahlgren, A.; Carling, C.; Pallesen, S.; Bjorvatn, B. A televised, web-based randomised trial of an herbal remedy (valerian) for insomnia. PLoS One, 2007, 2(10)e1040
[http://dx.doi.org/10.1371/journal.pone.0001040] [PMID: 17940604]
[224]
Kennedy, D.O.; Little, W.; Haskell, C.F.; Scholey, A.B. Anxiolytic effects of a combination of Melissa officinalis and Valeriana officinalis during laboratory induced stress. Phytother. Res., 2006, 20(2), 96-102.
[http://dx.doi.org/10.1002/ptr.1787] [PMID: 16444660]
[225]
Skórska, C.; Sitkowska, J.; Krysińska-Traczyk, E.; Cholewa, G.; Dutkiewicz, J. Exposure to airborne microorganisms, dust and endotoxin during processing of valerian roots on farms. Ann. Agric. Environ. Med., 2005, 12(1), 119-126.
[PMID: 16028876]
[226]
Hallam, K.T.; Olver, J.S.; McGrath, C.; Norman, T.R. Comparative cognitive and psychomotor effects of single doses of Valeriana officianalis and triazolam in healthy volunteers. Hum. Psychopharmacol., 2003, 18(8), 619-625.
[http://dx.doi.org/10.1002/hup.542] [PMID: 14696021]
[227]
Poyares, D.R.; Guilleminault, C.; Ohayon, M.M.; Tufik, S. Can valerian improve the sleep of insomniacs after benzodiazepine withdrawal? Prog. Neuropsychopharmacol. Biol. Psychiatry, 2002, 26(3), 539-545.
[http://dx.doi.org/10.1016/S0278-5846(01)00305-0] [PMID: 11999905]
[228]
Palmieri, G.; Contaldi, P.; Fogliame, G. Evaluation of effectiveness and safety of a herbal compound in primary insomnia symptoms and sleep disturbances not related to medical or psychiatric causes. Nat. Sci. Sleep, 2017, 9, 163-169.
[http://dx.doi.org/10.2147/NSS.S117770] [PMID: 28603433]
[229]
Wheatley, D. Kava and valerian in the treatment of stress-induced insomnia. Phytother. Res., 2001, 15(6), 549-551.
[http://dx.doi.org/10.1002/ptr.840] [PMID: 11536390]
[230]
Cerny, A.; Schmid, K. Tolerability and efficacy of valerian/lemon balm in healthy volunteers (a double-blind, placebo-controlled, multicentre study). Fitoterapia, 1999, 70(3), 221-228.
[http://dx.doi.org/10.1016/S0367-326X(99)00018-0]
[231]
Meier, S.; Haschke, M.; Zahner, C.; Kruttschnitt, E.; Drewe, J.; Liakoni, E.; Hammann, F.; Gaab, J. Effects of a fixed herbal drug combination (Ze 185) to an experimental acute stress setting in healthy men - An explorative randomized placebo-controlled double-blind study. Phytomedicine, 2018, 39, 85-92.
[http://dx.doi.org/10.1016/j.phymed.2017.12.005] [PMID: 29433687]
[232]
Mineo, L.; Concerto, C.; Patel, D.; Mayorga, T.; Paula, M.; Chusid, E.; Aguglia, E.; Battaglia, F. valeriana officinalis root extract modulates cortical excitatory circuits in humans. Neuropsychobiology, 2017, 75(1), 46-51.
[http://dx.doi.org/10.1159/000480053] [PMID: 29035887]
[233]
Thomas, K.; Canedo, J.; Perry, P.J.; Doroudgar, S.; Lopes, I.; Chuang, H.M.; Bohnert, K. Effects of valerian on subjective sedation, field sobriety testing and driving simulator performance. Accid. Anal. Prev., 2016, 92, 240-244.
[http://dx.doi.org/10.1016/j.aap.2016.01.019] [PMID: 27110643]
[234]
Khan, A.U.; Gilani, A.H. Antidiarrhoeal and bronchodilatory potential of Valeriana wallichii. Nat. Prod. Res., 2012, 26(11), 1045-1049.
[http://dx.doi.org/10.1080/14786419.2010.551754] [PMID: 22010976]
[235]
Nam, S.M.; Choi, J.H.; Yoo, D.Y.; Kim, W.; Jung, H.Y.; Kim, J.W.; Kang, S.Y.; Park, J.; Kim, D.W.; Kim, W.J.; Yoon, Y.S.; Hwang, I.K. Valeriana officinalis extract and its main component, valerenic acid, ameliorate D-galactose-induced reductions in memory, cell proliferation, and neuroblast differentiation by reducing corticosterone levels and lipid peroxidation. Exp. Gerontol., 2013, 48(11), 1369-1377.
[http://dx.doi.org/10.1016/j.exger.2013.09.002] [PMID: 24055511]
[236]
Wang, Q.; Wang, C.; Zuo, Y.; Wang, Z.; Yang, B.; Kuang, H. Compounds from the roots and rhizomes of Valeriana amurensis protect against neurotoxicity in PC12 cells. Molecules, 2012, 17(12), 15013-15021.
[http://dx.doi.org/10.3390/molecules171215013] [PMID: 23250029]
[237]
De Smet, P.A.G.M. Health risks of herbal remedies. Drug Saf., 1995, 13(2), 81-93.
[http://dx.doi.org/10.2165/00002018-199513020-00003] [PMID: 7576267]
[238]
Rendic, S.; Di Carlo, F.J. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers, and inhibitors. Drug Metab. Rev., 1997, 29(1-2), 413-580.
[http://dx.doi.org/10.3109/03602539709037591] [PMID: 9187528]
[239]
Beaubrun, G.; Gray, G.E. A review of herbal medicines for psychiatric disorders. Psychiatr. Serv., 2000, 51(9), 1130-1134.
[http://dx.doi.org/10.1176/appi.ps.51.9.1130] [PMID: 10970915]